AIDS Wasting in Women: Anabolic Effects of Testosterone

Completed · Phase 2

Conditions studied: AIDS Wasting Syndrome

In brief

The study is a 6 month, placebo-controlled study of transdermal testosterone for women with HIV-associated weight loss. Women with AIDS wasting have been found to have low testosterone levels. This study is designed to test the efficacy of physiologic testosterone dosing to improve weight, muscle mass and quality of life indices, including energy level, appetite and libido, in androgen deficient women with AIDS wasting. After 6 months, all women receive open label transdermal testosterone for an additional 6 months.

Key facts

Study ID
NCT00006158
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Starts
1998-09-01
Expected to finish
2004-12-01
Last updated by the study team
2010-02-15

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.